share_log

Opinion: The 6 best penny stocks to buy for September

Opinion: The 6 best penny stocks to buy for September

点评:9月份最值得买入的6只便宜股
InvestorPlace ·  2021/08/30 11:56  · 观点

There is no question that the pandemic has brought a significant increase in day traders. And for many of these traders, penny stocks are a convenient investment of choice.

毫无疑问,大流行带来了日内交易者的大幅增加。对于这些交易员中的许多人来说,细价股是一种方便的投资选择。

There’s no “right” definition for what constitutes a penny stock. Some investors will say the stock must be trading below $1. Others may put the threshold at $5; some may go as high as $10. The general point is that penny stocks are inexpensive to buy.

对于什么是细价股,没有“正确”的定义。一些投资者会说,股票的交易价格一定在1美元以下。另一些人可能会把门槛定在5美元,有些人可能会高达10美元。大体上来说,购买细价股并不贵。

But along with that low price comes a significant risk. After all, many penny stocks are trading at a low price for a reason. And one reason could be that the company is under significant financial duress.

但伴随着低价而来的是一个巨大的风险。毕竟,许多低价股的交易价格较低是有原因的。其中一个原因可能是该公司面临巨大的财务压力。

However, if an investor is willing to accept that risk and do a little research, investing in penny stocks can be an intriguing numbers game. After all, with so many to choose from, a handful will undoubtedly turn out to be winners. And when you factor in that many of today’s retail investors aren’t buy-and-hold investors, there’s even more incentive to take a risk on a few penny stocks.

然而,如果投资者愿意接受这种风险并做一些研究,投资细价股可能是一场有趣的数字游戏。毕竟,有这么多人可供选择,少数人无疑会成为赢家。如果你考虑到今天的许多散户投资者不是买入并持有的投资者,你就会更有动力去冒险购买几只便士股票。

And as the calendar turns to September, it’s a good time to take a look at six penny stocks that look like good buys.

随着日历转到9月份,现在是看一看看起来很划算的6只便宜股的好时机。

Penny Stocks: Romeo Power (RMO)

低价股:罗密欧电力公司(Romeo Power)

Romeo Power is a good example of the volatility that can be found in the price of penny stocks. One month ago, RMO stock closed at $7.05. But in that span, the stock fell to a closing low of $4.20. And as of this writing, the stock is trading at $5.02.

罗密欧电力公司(Romeo Power)就是一个很好的例子,说明了细价股价格的波动性。一个月前,RMO的股票收盘价为7.05美元。但在此期间,该股跌至4.20美元的收盘低点。在撰写本文时,该股的交易价格为5.02美元。

As for the company itself, Romeo Power is engaged in manufacturing of lithium-ion batteries for Class 1 to Class 8 commercial trucks. The company’s innovative design features “up to 30%” greater energy density than current lithium-ion batteries. For fleet operators, this means batteries would hold a charge longer and need to be recharged less frequently.

至于公司本身,罗密欧电力公司(Romeo Power)从事1至8级商用卡车用锂离子电池的制造。该公司的创新设计比目前的锂离子电池的能量密度高出“30%”。对于车队运营商来说,这意味着电池充电的时间更长,需要充电的频率更低。

Another benefit, according to the company, is that the battery will hold optimal temperature even in the parts of the country that are subject to extreme heat or cold.

据该公司称,另一个好处是,即使在美国极端炎热或寒冷的地区,电池也能保持最佳温度。

There is a lot of competition in this space, including from companies such as Hyliion (NYSE:HYLN) which are offering Class 8 trucks with their own innovative solutions. However, with solid-state batteries likely still a few years away, Romeo Power may have an opportunity to wedge itself into the conversation.

在这个领域有很多竞争,包括来自以下公司的竞争海利安纽约证券交易所代码:HYLN),它们提供具有自己的创新解决方案的8类卡车。然而,由于固态电池可能还需要几年时间,罗密欧电力公司(Romeo Power)可能有机会加入到这一对话中来。

Of the five analysts that have rated RMO stock, the consensus price target is $8.14 which would be a gain of over 60% from current levels.

在对RMO股票进行评级的五位分析师中,一致认为目标价为8.14美元,比目前水平上涨了60%以上。

Meta Materials (MMAT)

元材料(MMAT)

Many of the penny stocks on this list have been caught up in the meme stock movement at one time or another this year. And MMAT stock is no exception. At the end of June, the stock closed at $7.49 — a level investors had not seen for seven years. And with the price back down to $5.20 as of this writing, it’s fair to say that many traders took their profits and went looking for another target.

这份榜单上的许多细价股都在今年的某个时候卷入了表情包股票运动。MMAT股票也不例外。6月底,该股收于7.49美元,这是投资者七年来未曾见过的水平。在撰写本文时,随着金价回落至5.20美元,可以公平地说,许多交易员获利回吐,转而寻找另一个目标。

Meta Materials manufactures and develops “functional materials” and is known for being on the cutting edge of technological breakthroughs in this area. Essentially the company is looking to develop intellectual property that it can sell to the right partners.

Meta Materials制造和开发“功能材料”,并以处于该领域技术突破的前沿而闻名。从本质上说,该公司正在寻求开发知识产权,以便出售给合适的合作伙伴。

The company recently formed a scientific advisory board which is likely to allow the company to develop stronger, more diverse products.

该公司最近成立了一家科学顾问委员会这可能会让该公司开发出更强大、更多样化的产品。

This is far from a sure thing. But for investors looking for a penny stock that could have some growth for the remainder of 2021, I’d encourage you to keep Meta Materials on your watch list. If it breaks past a point of resistance, there could be some short-term upside.

这远非板上钉钉的事。但对于寻找在2021年剩余时间内可能有一些增长的细价股的投资者来说,我建议你将Meta Material留在你的观察名单上。如果突破阻力位,短期内可能会有一些上行空间。

Penny Stocks: Biolase (BIOL)

细价股:Biolase(Biol)

One way to evaluate the value of a penny stock investment is to look at its potential market. And that’s why Biolase is a penny stock that merits consideration.

评估细价股投资价值的一种方法是看它的潜在市场。这就是为什么Biolase是一只值得考虑的便士股票。

The company produces medical devices for the dental industry. This was a sector that was devastated as many dentist’s offices closed for obvious reasons.

该公司为牙科行业生产医疗器械。这是一个被摧毁的领域,因为许多牙医的诊所因为显而易见的原因而关闭。

But with the economy restarting, Biolase looks like a strong reopening stock. Investors seem to agree. After being part of the meme stock movement in January and February, BIOL stock has charged ahead more than 30% in the past month.

但随着经济重启,Biolase看起来像是一只强劲的重新开盘股票。投资者似乎对此表示同意。在1月和2月成为表情包股票运动的一部分后,Biol股票在过去一个月里上涨了30%以上。

Biolase holds over 270 patents with 40 other technologies patent-pending as of this writing. And the company has sold its products in 80 countries. Analyst sentiment looks positive, with an average price target of $2.25. One reason for that may have been the company’s appointment of three new board members who have significant experience in the dental industry.

截至撰写本文时,Biolase拥有270多项专利,还有40项其他技术正在申请专利。该公司已在80个国家销售其产品。分析师的情绪看起来很积极,平均目标价为2.25美元。其中一个原因可能是该公司任命了三名在牙科行业拥有丰富经验的新董事会成员。

MannKind Corp (MNKD)

曼肯德公司(MannKind Corp)

You’ll find a lot of biopharmaceutical companies like MannKind among lists of penny stocks. One reason for this is that these companies frequently are in the “pre-revenue” stage (i.e. they don’t have a product that’s in market yet).

在廉价股名单中,你会发现很多像曼肯德这样的生物制药公司。其中一个原因是这些公司经常处于“预收”阶段(即他们还没有产品上市)。

That’s not the case for MannKind, which has managed to get a product approved and is in use. The main product — Afrezza — is a prescription glucose management product that is inhaled as a powder. The therapeutic is approved for adult use. MannKind is also peripherally involved in developing a therapeutic, which may explain some of its volatility. However, because it has Afrezza, investors don’t have to rely on that product panning out.

但MannKind的情况并非如此,它已经设法让一款产品获得批准并投入使用。主要产品Afrezza是一种处方药葡萄糖管理产品,可作为粉末吸入。这种疗法被批准成人使用。MannKind还在外围参与了一种治疗药物的开发,这可能可以解释它的一些波动性。然而,因为它拥有Afrezza,投资者不必依赖该产品的成功。

That being said, MNKD stock has closed over $6 a share this year and it’s traded under $5.

话虽如此,MNKD股票今年的收盘价已超过每股6美元,目前交易价格低于5美元。

The consensus opinion among six analysts gives the stock a 25% upside from its current level.

六位分析师的一致意见认为,该股较当前水平上涨25%。

Penny Stocks: DatChat Inc. (DATS)

细价股:DatChat Inc.(DATS)

If you’re a risk-tolerant investor, it can be exciting to get in on the ground floor of a newly public company. And that’s your opportunity with DatChat. The company just began publicly trading shares on Aug. 13, 2021.

如果你是一位风险承受力强的投资者,进入一家新上市公司的底层可能会令人兴奋。这就是你使用DatChat的机会。该公司刚刚于2021年8月13日开始公开交易股票。

And you can say it’s been a success. DATS stock has nearly doubled in the two weeks that it has been trading. It’s already well over $7, straining all but the most lenient of penny stock definitions.

你可以说这是一次成功。DATS的股票在其交易的两周内几乎翻了一番。它已经远远超过了7美元,除了最宽松的细价股定义之外,所有的定义都变得紧张起来。

Of course, it could also crash. That’s the risk with penny stocks. But let’s keep our eyes on the bullish side of this stock. DatChat is a technology company that creates communication software for, among other things, mobile messaging applications. The company’s signature product, DatChat Messenger emphasizes privacy and protection. Plus, the company is developing a blockchain-based communications platform which is adding to the buzz around the company.

当然,它也可能崩溃。这就是细价股的风险所在。但让我们关注这只股票看涨的一面。DatChat是一家技术公司,专门为移动通讯应用程序等开发通信软件。该公司的标志性产品DatChat Messenger强调隐私和保护。此外,该公司正在开发一个基于区块链的通信平台,这增加了围绕该公司的热议。

The combination of a tech startup and the blockchain will likely make DATS stock irresistible to day traders. And that means it may be a short squeeze candidate eventually. However, it’s definitely a stock that should be on your watch list.

一家科技初创公司与区块链的结合可能会让DATS股票对日内交易者具有不可抗拒的吸引力。这意味着它最终可能是一个短期挤压的候选人。然而,它绝对是一只应该出现在你的观察名单上的股票。

Inuvo (INUV)

因纽沃(Inuvo)

The last of the penny stocks to consider is a true penny stock. That is, INUV stock is trading for less than $1 per share as of this writing. Inuvo provides targeted media and display advertising solutions for eCommerce companies. That puts the company firmly in the vanguard of the explosive growth in e-commerce in the last year.

最后一个要考虑的细价股是真正的细价股。也就是说,在撰写本文时,INUV的股票交易价格不到每股1美元。因纽沃为电子商务公司提供有针对性的媒体和展示广告解决方案。这使该公司牢牢地站在了去年电子商务爆炸性增长的先锋地位。

At one point this year, INUV stock was trading for over $2. But it’s now hovering around 72 cents a share. That’s still about a 60% gain for investors who bought shares at the beginning of the year. However, it also illustrates the risk and the reward that can come with investing in penny stocks.

今年,INUV的股价一度超过2美元,但现在徘徊在每股72美分左右。对于年初买入股票的投资者来说,这仍是60%左右的收益。然而,它也说明了投资细价股可能带来的风险和回报。

The company is not yet profitable. However, it beat analysts’ expectations for revenue. In its most recent quarter, revenue came in 66% higher on a year-over-year basis.

该公司尚未实现盈利。然而,它超出了分析师对收入的预期。在最近一个季度,该公司营收同比增长66%。

And the company offered guidance that suggests double-digit revenue gains are likely to continue. And as they do, Inuvo expects that it will begin to post positive EBITDA.

该公司提供的指引表明,两位数的收入增长可能会持续下去。随着他们这样做,因纽沃预计它将开始公布正的EBITDA。

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

关于细价股和低成交量股票: 除了极少数例外,不会发布关于市值低于1亿美元或每天交易量低于100,000股的公司的评论。这是因为这些“廉价股”经常是诈骗艺术家和市场操纵者的游乐场。如果我们对可能受我们的评论影响的低成交量股票发表评论,我们要求InvestorPlace.com该书的作者披露了这一事实,并警告读者其中的风险。

On the date of publication, Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

在出版之日,克里斯·马科赫(Chris Markoch)没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点,以InvestorPlace.com为准出版指南.

Chris Markoch is a freelance financial copywriter who has been covering the market for seven years. He has been writing for InvestorPlace since 2019.

克里斯·马科赫(Chris Markoch)是一名自由财经文案,已经报道该市场七年了。自2019年以来,他一直在为InvestorPlace写作。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发